Sarepta Therapeutics
(SRPT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2015 | 06-2015 | 03-2015 | 12-2014 | 09-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -155,349 | -103,410 | -61,559 | -135,789 | -91,373 |
| Depreciation Amortization | 4,688 | 3,184 | 1,595 | 6,122 | 4,380 |
| Accounts receivable | -317 | 0 | 0 | 1,114 | 168 |
| Other Working Capital | 6,519 | 8,129 | 2,329 | -22,136 | -33,506 |
| Other Operating Activity | 26,266 | 20,218 | 14,287 | 22,150 | 17,241 |
| Operating Cash Flow | $-118,193 | $-71,879 | $-43,348 | $-128,539 | $-103,090 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 92,222 | 49,019 | 44,750 | -139,455 | -185,590 |
| PPE Investments | -2,316 | -1,169 | -532 | -25,444 | -22,305 |
| Purchase Of Investment | -10,695 | N/A | N/A | N/A | 0 |
| Sale Of Investment | N/A | N/A | N/A | 7,250 | 3,250 |
| Purchase Sale Intangibles | -982 | -640 | -391 | -1,381 | -1,062 |
| Other Investing Activity | -982 | -640 | -391 | -1,381 | -1,062 |
| Investing Cash Flow | $78,229 | $47,210 | $43,827 | $-159,030 | $-205,707 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 19,601 | 19,734 | N/A | N/A | 0 |
| Debt Repayment | -2,573 | -49 | -25 | -94 | -70 |
| Common Stock Issued | 5,204 | 971 | 431 | 104,249 | 104,201 |
| Financing Cash Flow | $22,232 | $20,656 | $406 | $104,155 | $104,131 |
| Beginning Cash Position | 73,551 | 73,551 | 73,551 | 256,965 | 256,965 |
| End Cash Position | 55,819 | 69,538 | 74,436 | 73,551 | 52,299 |
| Net Cash Flow | $-17,732 | $-4,013 | $885 | $-183,414 | $-204,666 |
| Free Cash Flow | |||||
| Operating Cash Flow | -118,193 | -71,879 | -43,348 | -128,539 | -103,090 |
| Capital Expenditure | -2,316 | -1,169 | -532 | -25,444 | -22,305 |
| Free Cash Flow | -120,509 | -73,048 | -43,880 | -153,983 | -125,395 |